Home

Vaxart, Inc. - Common Stock (VXRT)

0.5041
+0.1112 (28.30%)
NASDAQ · Last Trade: Jun 11th, 11:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.3929
Open0.5997
Bid0.4700
Ask0.4800
Day's Range0.4910 - 0.6213
52 Week Range0.2850 - 1.070
Volume94,620,862
Market Cap76.61M
PE Ratio (TTM)-2.965
EPS (TTM)-0.2
Dividend & YieldN/A (N/A)
1 Month Average Volume6,673,114

Chart

About Vaxart, Inc. - Common Stock (VXRT)

Vaxart Inc is a biotechnology company focused on developing oral vaccines based on its proprietary platform technology. The company aims to create innovative vaccines that are not only effective but also easy to administer, eliminating the need for needles. Vaxart's research and development primarily targets infectious diseases, with a particular emphasis on creating solutions for viral infections and other public health challenges. Through its unique oral delivery system, Vaxart strives to enhance patient compliance and broaden access to vaccination, ultimately contributing to global health improvement. Read More

News & Press Releases

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · June 11, 2025
Top movers analysis in the middle of the day on 2025-06-11: top gainers and losers in today's session.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · June 11, 2025
Which stocks are gapping on Wednesday?chartmill.com
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · June 11, 2025
Insights Ahead: Vaxart's Quarterly Earningsbenzinga.com
Via Benzinga · May 12, 2025
Earnings Scheduled For November 13, 2024benzinga.com
Via Benzinga · November 13, 2024
Earnings Preview For Vaxartbenzinga.com
Via Benzinga · November 12, 2024
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 11, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 11, 2025
Why Stitch Fix Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 11, 2025
US Stocks Likely To Open Lower Ahead Of May Inflation Report: S&P 500 Still In A 31-Month-Long Bull Market, 'Better Times Are Coming,' Says Expertbenzinga.com
Via Benzinga · June 11, 2025
Earnings Scheduled For March 20, 2025benzinga.com
Via Benzinga · March 20, 2025
Earnings Scheduled For May 13, 2025benzinga.com
Via Benzinga · May 13, 2025
Top movers in Monday's sessionchartmill.com
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · February 24, 2025
These stocks are moving in today's sessionchartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · February 24, 2025
There are notable gap-ups and gap-downs in today's session.chartmill.com
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · February 24, 2025
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upsidebenzinga.com
Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus.
Via Benzinga · August 15, 2024
VXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024investorplace.com
VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buyingbenzinga.com
Via Benzinga · June 21, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · June 19, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · June 18, 2024
Vaxart Stock Is Moving Higher After The Bell: What's Going On?benzinga.com
Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project NextGen award are expected to extend the company's cash runway into 2026.
Via Benzinga · June 17, 2024
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offeringbenzinga.com
Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study.
Via Benzinga · June 14, 2024
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 14, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Fridayinvestorplace.com
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
Via InvestorPlace · June 14, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · June 13, 2024